View Author
virus vaccine influenza vaccination fluenza study response antibody group patient strain subject trial difference protection table infection antibody response titre control value titer sample result number netherland antigen influenza vaccination fc virus disease effect fluenza virus adult influenza vaccine population increase species outbreak reaction children vaccinated fluenza vaccines mortality t-cell fluenza vaccine serum method assay subtype beyer analysis paper cc virus level model influenza virus post-vaccination prevaccination postvaccination ratio meta-analysi isolation fluenza viruses replication comparison health subunit immunization epidemic iscom immunogenicity virus isolation protection rates surveillance article protection rate virol parameter preparation influenza vaccines
10 Most Recent Publications
|
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption
(Article)
Allard, S.D. Keersmaecker, B. de Padmos, I. Thielemans, K. Osterhaus, A.D.M.E. Lacor, P. Ende, M.E. van der Aerts, J.L. Baalen, C.A. van Gruters, R.A. Goede, A.L. de Verschuren, E.J. Koetsveld, J. Reedijk, M.L. Wylock, C. Beyer, W.E.Ph. Eilers, P.H. Corthals, J. |
2012-03-01
|
|
Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis
(Article)
Beyer, W.E.Ph. Nauta, J.J.P. Palache, A.M. Giezeman, K.M. Osterhaus, A.D.M.E. |
2011-08-05
|
|
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host
(Article)
Wit, E. de Munster, V.J. Riel, D.A.J. van Beyer, W.E.Ph. Rimmelzwaan, G.F. Kuiken, T. Osterhaus, A.D.M.E. Fouchier, R.A.M. |
2010-02-01
|
|
Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002
(Article)
Voordouw, A.C.G. Beyer, W.E.Ph. Smith, D.J. Sturkenboom, M.C.J.M. Stricker, B.H.Ch. |
2009-12-11
|
|
On the relationship between mean antibody level, seroprotection and clinical protection from influenza
(Article)
Nauta, J.J.P. Beyer, W.E.Ph. Osterhaus, A.D.M.E. |
2009-08-01
|
|
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests
(Article)
Munster, V.J. Baas, C. Fouchier, R.A.M. Lexmond, P. Bestebroer, T.M. Guldemeester, J. Beyer, W.E.Ph. Wit, E. de Schutten, M. Rimmelzwaan, G.F. Osterhaus, A.D.M.E. |
2009-03-01
|
|
Mortality benefits of influenza vaccination in elderly people
(Article)
Thijs, C. Beyer, W.E.Ph. Govaert, P.M. Sprenger, M.J.W. Dinant, G.J. Knottnerus, J.A. |
2008-08-01
|
|
Influenza vaccine dosages
(Letter To Editor)
Palache, A.M. Beyer, W.E.Ph. Osterhaus, A.D.M.E. |
2008-05-01
|
|
The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination
(Article)
Gelinck, L.B.S. Bijl, A.E. van der Beyer, W.E.Ph. Visser, L.G. Huizinga, T.W.J. Hogezand, R.A. van Rimmelzwaan, G.F. Kroon, F.P. |
2008-05-01
|
|
Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1)
(Article)
Keawcharoen, J. Riel, D.A.J. van Amerongen, G. van Bestebroer, T.M. Beyer, W.E.Ph. Lavieren, R.F. van Osterhaus, A.D.M.E. Fouchier, R.A.M. Kuiken, T. |
2008-04-01
|
